RÉDUCTION DE LA CHARGE TUMORALE PAR L'ADMINISTRATION D'ANTAGONISTES DE CCR1 EN ASSOCIATION AVEC DES INHIBITEURS DE PD-1 OU DES INHIBITEURS DE PD-L1

• 收藏
• 分享

专利权人:

ChemoCentryx; Inc.

发明人:

CHARO, Israel,JUNG, Heiyoun,SCHALL, Thomas, J.,ZHANG, Penglie

申请号：

EP17779801

公开号：

EP3439653A4

申请日:

2017.04.06

申请国别(地区):

EP

年份:

2019

代理人:

摘要：

The present invention provides methods for reducing tumor burden, tumor growth, tumor progression, and/or metastasis in a subject suffering from a solid tumor cancer such as triple negative breast cancer. The methods include administering to a subject in need thereof a therapeutically effective amount of a PD-L1 inhibitor or a PD-1 inhibitor in combination with a small molecule chemokine receptor antagonist that blocks CCR1.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/